Phys.OrgScientists make it possible to rank the risk of resistance genesPhys.OrgThe researchers exploited synthetic biology to sample a large mechanistic diversity of resistance genes to investigate the impact of gene transfer on a new bacterial host. … Continue reading
pharmaphorum |
No safety concerns so far in Sangamo’s groundbreaking gene-editing trial
pharmaphorum The trial of Sangamo’s gene-editing treatment for a rare and debilitating disease has got off to a good start, with no safety concerns reported so far. The groundbreaking trial hit the headlines around the world in November when Brian Madeux … |
Houston Chronicle |
A&M and Celltex partner on stem cell Alzheimer’s research
Houston Chronicle Under a new state law that sanctions experimental stem cell therapy in Texas, Celltex hopes to again begin providing its stem cells to doctors and hospitals in the state, said Eller. Celltex, he said, is waiting on rules being drawn up by the Texas … Texas A&M Institute for Regenerative Medicine and Celltex Therapeutics Enter Agreement for Alzheimer’s ResearchBusiness Wire (press release) |
Houston Chronicle |
A&M and Celltex partner on stem cell Alzheimer’s research
Houston Chronicle Under a new state law that sanctions experimental stem cell therapy in Texas, Celltex hopes to again begin providing its stem cells to doctors and hospitals in the state, said Eller. Celltex, he said, is waiting on rules being drawn up by the Texas … |
The Japan Times |
Second man has gene editing in California as therapy raises no safety flags so far on first one
The Japan Times Madeux also had a severe cough and a partially collapsed lung, but these were deemed unrelated to the gene therapy because he had had similar problems previously. Importantly, there were no signs of harm to his liver. “That’s the big worry” because … |